Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma

Chimeric antigen receptor (CAR) T-cell therapy targeting cluster of differentiation (CD)19 has had a transformative impact on patient outcomes in a subset of patients with relapsed/refractory non-Hodgkin lymphoma. We present a patient with refractory large B-cell lymphoma in complete remission for 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahrendsen, Jared T., Sehgal, Kartik, Sarangi, Sasmit, Uhlmann, Erik J., Varma, Hemant, Arnason, Jon, Avigan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577592/
https://www.ncbi.nlm.nih.gov/pubmed/34804310
http://dx.doi.org/10.14740/jh903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577592/
https://www.ncbi.nlm.nih.gov/pubmed/34804310
http://dx.doi.org/10.14740/jh903

Ejemplares similares